Recent updates

Browse recent updates. BMJ Best Practice is continuously updated to provide the latest evidence-based decision support.

  • 15 Apr 2025Latest UK asthma guidance provides minimal change to exacerbation managementTopic: Acute asthma exacerbation in adults
  • 19 Mar 2025Esketamine approved in the US as the first ever monotherapy for treatment-resistant depression in adultsTopic: Depression in adults
  • 14 Mar 2025NICE recommends cytisinicline for smoking cessation, expanding treatment options for clinicians in the UKTopic: Smoking cessation
  • 14 Mar 2025Guidelines recommend statins for people living with HIV to prevent cardiovascular eventsTopic: HIV in adults
  • 05 Mar 2025FDA approves olezarsen for the treatment of familial chylomicronemia syndromeTopic: Hypertriglyceridaemia
  • 18 Feb 2025Gene-editing therapy, exagamglogene autotemcel, available through managed access agreement in National Health Service (NHS) EnglandTopic: Sickle cell anaemia
  • 11 Feb 2025First bird flu death reported in the US outbreak; case of human infection detected in the UKTopic: Avian influenza A (H5N1) virus infection
  • 17 Jan 2025WHO recommends first single-dose drug for Plasmodium vivax malariaTopic: Malaria
  • 10 Dec 2024WHO declares mpox outbreak in Africa a public health emergency of international concern; first cases of clade Ib mpox detected in US and UK​Topic: Mpox
  • 04 Dec 2024FDA grants approval of seladelpar, expanding options for second-line treatmentTopic: Primary biliary cholangitis
  • 19 Nov 2024WHO recommends fexinidazole for rhodesiense HATTopic: African trypanosomiasis
  • 15 Nov 2024Clinicians urged to consider parvovirus B19 in people with fever, myalgia, arthralgia, and rash, after US and Europe report increased casesTopic: Erythema infectiosum
  • 15 Nov 2024FDA approves palopegteriparatide for hypoparathyroidism in adultsTopic: Hypoparathyroidism
  • 30 Oct 2024Limit topical anesthetics to single use for initial symptom relief and to aid examinationTopic: Eye trauma
  • 11 Oct 2024Adrenaline (epinephrine): new intranasal formulation approved for management of anaphylaxisTopic: Anaphylaxis
  • 10 Oct 2024Limit topical anaesthetics to single use for initial symptom relief and to aid examinationTopic: Corneal abrasions
  • 04 Oct 2024Renaming of Ebola virus speciesTopic: Ebola disease
  • 01 Oct 2024Voxelotor withdrawn globally due to safety concernsTopic: Sickle cell anaemia